Details for New Drug Application (NDA): 019643

✉ Email this page to a colleague

NDA 019643 describes MEVACOR, which is a drug marketed by Merck and is included in one NDA. Additional details are available on the MEVACOR profile page.

The generic ingredient in MEVACOR is lovastatin. There are thirty-three drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the lovastatin profile page.

Summary for 019643

Tradename:	MEVACOR
Applicant:	Merck
Ingredient:	lovastatin
Patents:	0

Medical Subject Heading (MeSH) Categories for 019643

Anticholesteremic Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Approval Date:	Mar 28, 1991	TE:		RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	20MG Federal Register notice that product was not discontinued or withdrawn for safety or effectiveness reasons
Approval Date:	Aug 31, 1987	TE:		RLD:	Yes

Profile for product number 004

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	40MG Federal Register notice that product was not discontinued or withdrawn for safety or effectiveness reasons
Approval Date:	Dec 14, 1988	TE:		RLD:	Yes

Expired US Patents for NDA 019643

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Merck	MEVACOR	lovastatin	TABLET;ORAL	019643-002	Mar 28, 1991	4,231,938*PED	⤷ Get Started Free
Merck	MEVACOR	lovastatin	TABLET;ORAL	019643-004	Dec 14, 1988	4,231,938*PED	⤷ Get Started Free
Merck	MEVACOR	lovastatin	TABLET;ORAL	019643-003	Aug 31, 1987	4,231,938*PED	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.